Literature DB >> 19685200

Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis.

Marco Luigetti1, Amelia Conte, Francesca Madia, Giuseppe Marangi, Marcella Zollino, Irene Mancuso, Michele Dileone, Alessandra Del Grande, Vincenzo Di Lazzaro, Pietro Attilio Tonali, Mario Sabatelli.   

Abstract

Of all the SOD1 gene mutations described, uniquely the D90A mutation has been identified in recessive, dominant, and apparently sporadic cases. We describe a patient with a sporadic form of amyotrophic lateral sclerosis (ALS) in which a heterozygous A > C exchange at position 272 in the SOD1 gene was detected. This mutation results in an amino acid substitution of alanine for aspartate at position 90 (D90A). The patient had a 12-year history of disease characterized by slow progression. Clinical examination at last follow-up revealed predominant upper motor neuron (p-UMN) involvement, with atrophies only in distal muscle of upper limbs. Electrophysiological examination revealed lower and upper motor neuron involvement. Family history was negative for neurological disease. This report shows that D90A in heterozygous state may cause p-UMN phenotype with very slow progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685200     DOI: 10.1007/s10072-009-0125-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

1.  Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in Italy.

Authors:  Francesca Luisa Conforti; Teresa Sprovieri; Rosalucia Mazzei; Alessandra Patitucci; Carmine Ungaro; Stefano Zoccolella; Angela Magariello; Vincenzo La Bella; Alessandro Tessitore; Gioacchino Tedeschi; Isa Laura Simone; Giovanni Majorana; Paola Valentino; Luigi Citrigno; Annalia Gabriele; Francesco Bono; Maria Rosaria Monsurrò; Maria Muglia; Aldo Quattrone
Journal:  Amyotroph Lateral Scler       Date:  2009-02

2.  Heterozygous D90A-SOD1 mutation in an Italian ALS patient with atypical presentation.

Authors:  Paola Origone; Claudia Caponnetto; Maria Mascolo; Paola Mandich
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

3.  Motor system abnormalities in heterozygous relatives of a D90A homozygous CuZn-SOD ALS patient of finnish extraction.

Authors:  M Mezei; P M Andersen; H Stewart; M Weber; A Eisen
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

4.  D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis.

Authors:  W Robberecht; T Aguirre; L Van den Bosch; P Tilkin; J J Cassiman; G Matthijs
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

5.  Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family.

Authors:  C K Hand; V Mayeux-Portas; J Khoris; V Briolotti; P Clavelou; W Camu; G A Rouleau
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

6.  SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.

Authors:  Stefania Battistini; Fabio Giannini; Giuseppe Greco; Giuseppe Bibbò; Loreta Ferrera; Valeria Marini; Renzo Causarano; Michela Casula; Giuliana Lando; Maria Cristina Patrosso; Claudia Caponnetto; Paola Origone; Alessandro Marocchi; Alberto Del Corona; Gabriele Siciliano; Paola Carrera; Vincenzo Mascia; Marcello Giagheddu; Carlo Carcassi; Sandro Orrù; Cecilia Garrè; Silvana Penco
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

7.  Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase.

Authors:  P M Andersen; P Nilsson; V Ala-Hurula; M L Keränen; I Tarvainen; T Haltia; L Nilsson; M Binzer; L Forsgren; S L Marklund
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations.

Authors:  K Abe; M Aoki; M Ikeda; M Watanabe; S Hirai; Y Itoyama
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

9.  Natural history of young-adult amyotrophic lateral sclerosis.

Authors:  M Sabatelli; F Madia; A Conte; M Luigetti; M Zollino; I Mancuso; M Lo Monaco; G Lippi; P Tonali
Journal:  Neurology       Date:  2008-07-02       Impact factor: 9.910

10.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

View more
  4 in total

1.  Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.

Authors:  Ivan V Marjanović; Biljana Selak-Djokić; Stojan Perić; Milena Janković; Vladimir Arsenijević; Ivana Basta; Dragana Lavrnić; Elka Stefanova; Zorica Stević
Journal:  J Neurol       Date:  2017-04-25       Impact factor: 4.849

2.  Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H2O2.

Authors:  Elizaveta Ustyantseva; Sophia V Pavlova; Anastasia A Malakhova; Kirill Ustyantsev; Suren M Zakian; Sergey P Medvedev
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

3.  Individual Oligogenic Background in p.D91A-SOD1 Amyotrophic Lateral Sclerosis Patients.

Authors:  Giulia Gentile; Benedetta Perrone; Giovanna Morello; Isabella Laura Simone; Sebastiano Andò; Sebastiano Cavallaro; Francesca Luisa Conforti
Journal:  Genes (Basel)       Date:  2021-11-23       Impact factor: 4.096

4.  Superhuman cell death detection with biomarker-optimized neural networks.

Authors:  Jeremy W Linsley; Drew A Linsley; Josh Lamstein; Gennadi Ryan; Kevan Shah; Nicholas A Castello; Viral Oza; Jaslin Kalra; Shijie Wang; Zachary Tokuno; Ashkan Javaherian; Thomas Serre; Steven Finkbeiner
Journal:  Sci Adv       Date:  2021-12-08       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.